Regulus Therapeutics Inc (NASDAQ: RGLS) kicked off on Monday, down -4.08% from the previous trading day, before settling in for the closing price of $1.47. Over the past 52 weeks, RGLS has traded in a range of $1.08-$3.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 1867.07%. While this was happening, its average annual earnings per share was recorded 46.73%. With a float of $52.92 million, this company’s outstanding shares have now reached $65.50 million.
Considering the fact that the conglomerate employs 30 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 18.54%, operating margin of -14766.89%, and the pretax margin is -13783.77%.
Regulus Therapeutics Inc (RGLS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Regulus Therapeutics Inc is 19.21%, while institutional ownership is 77.29%. The most recent insider transaction that took place on Jul 25 ’24, was worth 7,280. In this transaction Director of this company bought 4,000 shares at a rate of $1.82, taking the stock ownership to the 6,740 shares. Before that another transaction happened on Jan 18 ’24, when Company’s Chief Financial Officer sold 5,468 for $1.19, making the entire transaction worth $6,510. This insider now owns 5,782 shares in total.
Regulus Therapeutics Inc (RGLS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 46.73% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.60% during the next five years compared to 50.96% growth over the previous five years of trading.
Regulus Therapeutics Inc (NASDAQ: RGLS) Trading Performance Indicators
Take a look at Regulus Therapeutics Inc’s (RGLS) current performance indicators. Last quarter, stock had a quick ratio of 13.65.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.08, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Regulus Therapeutics Inc (RGLS)
Compared to the last year’s volume of 1.27 million, its volume of 0.48 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 11.85%. Additionally, its Average True Range was 0.11.
During the past 100 days, Regulus Therapeutics Inc’s (RGLS) raw stochastic average was set at 2.48%, which indicates a significant decrease from 10.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 52.78% in the past 14 days, which was lower than the 74.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5491, while its 200-day Moving Average is $1.8722. Nevertheless, the first resistance level for the watch stands at $1.4733 in the near term. At $1.5365, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.5832. If the price goes on to break the first support level at $1.3634, it is likely to go to the next support level at $1.3167. Should the price break the second support level, the third support level stands at $1.2535.
Regulus Therapeutics Inc (NASDAQ: RGLS) Key Stats
The company with the Market Capitalisation of 91.74 million has total of 65,466K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -30,040 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -11,040 K.
